LOS ANGELES—The Los Angeles County Department of Public Health announced April 14 it recently identified a case of hepatitis A linked to a multistate outbreak from frozen organic strawberries imported from Mexico and sold in Los Angeles County. The Food and Drug Administration has recalled several brands of frozen strawberries, and different suppliers are taking…
Hepatitis A Case Linked to Recalled Frozen Strawberries Sold in Los Angeles County
April 14, 2023
admin
Californiafrozen strawberriesHepatitis A OutbreakLos Angeles County Department of Public HealthRegional & State NewsSouthern CaliforniaState NewsThe Food and Drug AdministrationUS
0 Comment
Paxlovid, Advertised for Mass Use, Has Contraindications With Hundreds of Drugs
December 13, 2022
admin
AMERICACCP Virusjack askinsJohn Hughesmichael lamPaxlovidPUBLIC HEALTH INFORMATIONritonavirsabine hazanThe Food and Drug Administrationyusuf saleeby
0 Comment
One of the most robustly campaigned and well-known drugs for treating COVID is Paxlovid. Yet the drug’s limited clinical studies and numerous drug interactions raise questions of safety for COVID patients. Approved for Emergency Use Authorization (EUA) in December 2021 and promoted by the Food and Drug Administration (FDA), health officials, and politicians alike, Paxlovid…
Highly Prescribed ‘Benign’ Medication Detected in 10 Percent of Overdose Deaths
July 13, 2022
admin
BrighthealthHealth 1+1health care systemHealth SciencemedicineMen's Healthoff-labelpainkillerPfizerThe Food and Drug AdministrationUSUS News
0 Comment
A commonly prescribed painkiller and anticonvulsant (seizure medication) widely believed to be “benign” has become increasingly associated with overdose deaths in the United States. The medication is gabapentin, commonly marketed as Neurontin, Horizant, and Gralise. Over the years, gabapentin prescribing has steadily increased, with 64 million prescriptions dispensed in 2016, making the drug the 10th…
Fixed Packaging of Alzheimer’s Drug May Waste $605 Million a Year for Medicare, Experts Warn
July 6, 2022
admin
AduhelmAlzheimer’sBrighthealthHealth NewsHealthcare SystemmedicineThe Food and Drug AdministrationUniversity of CaliforniaUSUS News
0 Comment
Medicare could potentially waste up to $605 million annually from the packaging of controversial Alzheimer’s drug aducanumab if it is approved for widespread use, according to a University of California Los Angeles (UCLA) study. “Given Medicare’s premium increase in 2022 partly due to aducanumab, greater focus on efficient vial packaging could improve the value of…
FDA Warns Against Use of Neck Floats After Death of Baby
July 5, 2022
admin
BrightchildrenhealthHealth NewsHealthcare Systemneck floatrecallThe Food and Drug AdministrationUSUS News
0 Comment
Baby neck floats are under fire again after the Food and Drug Administration (FDA) warned against their use in water therapies following the death of one baby and hospitalization of another in unsupervised usage. “Do not use baby neck floats for water therapy intervention,” the FDA wrote in a media statement released on June 28….
FDA Issues Two Warning Letters to E-cigarette Businesses for Unauthorized Sales
June 29, 2022
admin
biden administrationBusiness & MarketsCompaniese-cigarettesPolicies & ImpactsThe Food and Drug AdministrationUSUS News
0 Comment
The Food and Drug Administration (FDA) posted warning letters on June 28 to two e-cigarette businesses, VAPORIZIT LLC and Elk River Vapor Shop, for selling e-cigarette products not previously on the market. According to the Federal Food, Drug, and Cosmetic Act, new tobacco products, including vapes, need a pre-market authorization order to be sold in…
FDA Bans JUUL E-Cigarettes
June 23, 2022
admin
BrightBusiness & MarketsCompaniese-cigaretteshealthHealth NewsPolicies & ImpactsThe Food and Drug AdministrationUSUS News
0 Comment
The Food and Drugs Administration (FDA) banned all of JUUL Labs Inc’s products on June 23 from the market, delivering a blow to the popular e-cigarette company. “Today’s action is further progress on the FDA’s commitment to ensuring that all e-cigarette and electronic nicotine delivery system products currently being marketed to consumers meet our public…
FDA Advisory Panel Rejects Acadia’s Antipsychotic for Alzheimer’s
June 22, 2022
admin
Alzheimer's diseaseBrighthealthHealth NewsParkinson's diseaseThe Food and Drug AdministrationUSUS News
0 Comment
The U.S. Food and Drug Administration advisory panel voted against the approval of Acadia Pharmaceutical’s drug for hallucinations and delusions associated with Alzheimer’s disease psychosis on Friday. The advisory voted 3 to 9 with no abstention after eight hours of discussion. The panel concluded that the studies were not enough to support the efficacy of…
94 Percent of Medication Not Supported by High-Quality Evidence, Harms Underreported: Study
June 19, 2022
admin
BrightdrughealthHealth NewsHealth ScienceHealthcare SystemMedicationThe Food and Drug AdministrationUKUSUS NewsWorld
0 Comment
Less than 6 percent of medical drugs have high-quality evidence to support their benefits, according to a recent study by the University of Oxford. The study found that, of the 1,567 eligible medications approved under the Cochrane Reviews from 2008 to 2021, more than 94 percent were not supported by high-quality evidence. Cochrane Reviews is…
Existing Cancer Therapy Demonstrates Significant Effect Against Other Cancers: Study
June 12, 2022
admin
BrightcancerhealthHealth ConditionsHealth NewsNews & Discoveriespancreatic cancerThe Food and Drug AdministrationUSUS News
0 Comment
An approved cancer therapeutic, once used in only 1 percent of cancers, may have significant uses in the remaining 99 percent, according to a new study. “Ivosidenib, previously called AG-120, may be applicable to the large majority of cancers,” said senior author Dr. Jordan Winter, division chief of surgical oncology at University Hospitals Seidman Cancer Center in…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`